SCHOTT Pharma AG & Co. KGaA | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Headlines Articles Press releases SCHOTT Pharma AG & Co. KGaA

Home
Companies
SCHOTT Pharma AG & Co. KGaA

BRIEF

published on 05/06/2025 at 07:05, 6 months 30 days ago

TPG's Strategic Investment in SCHOTT Poonawalla Enhances Joint Venture Growth

Joint Venture SCHOTT Pharma India Market Serum Institute TPG Investment
PRESS RELEASE

published on 05/06/2025 at 07:00, 6 months 30 days ago

SCHOTT Pharma and Serum Institute of India welcome new partner to Joint Venture in India; TPG makes strategic investment in SCHOTT Poonawalla
SCHOTT Pharma and Serum Institute of India welcome TPG as a new partner in their joint venture in India, with a strategic investment in SCHOTT Poonawalla

Pharmaceuticals Investment SCHOTT Pharma TPG Serum Institute Of India
BRIEF

published on 04/10/2025 at 18:20, 7 months 24 days ago

SCHOTT Pharma Exceeds Q2 2025 Market Expectations

Revenue Growth EBITDA Margin SCHOTT Pharma Market Expectations Q2 2025 Figures
PRESS RELEASE

published on 04/10/2025 at 18:15, 7 months 24 days ago

EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma: Preliminary Q2 2025 figures exceed capital market expectations
SCHOTT Pharma AG & Co. KGaA exceeds Q2 2025 expectations with EUR 252m revenues, EUR 72m EBITDA, and 28.6% EBITDA margin, maintaining full-year guidance. Detailed results on May 15, 2025

Revenues EBITDA SCHOTT Pharma Full-year Guidance Q2 2025
BRIEF

published on 04/10/2025 at 16:03, 7 months 24 days ago

SCHOTT Pharma Opens New Production Facility in Serbia

European Market SCHOTT Pharma Pharmaceutical Manufacturing Serbia Facility Glass Ampoules
PRESS RELEASE

published on 04/10/2025 at 15:58, 7 months 24 days ago

Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe
SCHOTT Pharma opens new production facility in Serbia to strengthen competitiveness in Europe, creating 180 new jobs and increasing ampoule manufacturing capacity

SCHOTT Pharma Competitiveness Serbia Production Facility Ampoule Manufacturing
BRIEF

published on 02/13/2025 at 07:05, 9 months 20 days ago

SCHOTT Pharma Begins Fiscal Year 2025 with Promising Results

Revenue Growth EBITDA Margin Q1 Results High-value Solutions DCS Segment
PRESS RELEASE

published on 02/13/2025 at 07:00, 9 months 20 days ago

SCHOTT Pharma records good start into fiscal year and confirms full year outlook
SCHOTT Pharma reports good start in Q1 2025 with EUR 230m revenues, confirms full year outlook. EBITDA margin at 25.1% as reported. High-value solutions share at 55%

Revenues EBITDA Margin SCHOTT Pharma Full Year Outlook Q1 2025
BRIEF

published on 02/04/2025 at 18:27, 10 months ago

SCHOTT Pharma Holds Successful Annual General Meeting

Annual General Meeting Shareholder Approval SCHOTT Pharma Profit Growth MDAX Promotion
PRESS RELEASE

published on 02/04/2025 at 18:22, 10 months ago

SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all agenda items
SCHOTT Pharma's successful Annual General Meeting for FY 2024 with all agenda items approved by shareholders, including new Supervisory Board member Dr. Wolfram Carius and KPMG as new auditor

Annual General Meeting Shareholders SCHOTT Pharma KPMG Dr. Wolfram Carius

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 36 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 41 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 11 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 6 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 11 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 07:00, 11 minutes ago

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 40 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 20 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 45 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 56 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

Les Echos

Published on 12/04/2025 at 18:00, 13 hours 11 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 26 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 27 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE